PTAB

IPR2018-01678

Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

09/10/18

Institution04/03/19

FWD05/29/20

Close05/29/20

StatusFinal Written Decision

OutcomeUnpatentable

Appeals

Administrative Patent Judges

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Bart A Gerstenblith	500+	50%	50%
James J Mayberry	500+	50%	50%
James A Tartal	500+	50%	50%
Hyun J Jung	500+	50%	50%

Petitioner

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A
Biocon Ltd	L3 A

No Parties

Attorney

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 A
Patrick J. Coyne	L5 A
Neal S. Cohen	L5 A
Peter Kinsella	L5 A
Scott E. Holwick	L5 A
Robert D. Bajefsky	L5 A

No Attorneys

Respondent

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Sanofi Inc	L4 E
Sanofi-Aventis US LLC	L4 E

No Parties

Attorney

No Attorneys